Constanza Pérez de la Puente

Instituto Alexander Fleming — Argentina

Biochemistry, Genetics and Molecular Biology · Life Sciences

2h-index24citations13works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(3), Lung Cancer Treatments and Mutations(2), HER2/EGFR in Cancer Research(2), Cancer Genomics and Diagnostics(2), Advanced Breast Cancer Therapies(2)

Publications13 total

Efficacy and toxicity of endocrine therapy + cyclin-dependent kinases 4/6 inhibitors (iCDK4/6) in metastatic breast cancer patients according to gBRCA status
Annals of Oncology·2018· 1 citedOpen Access
High neutrophil to lymphocyte ratio and decreased CD69<sup>+</sup>NK cells represent a phenotype of high risk in early-stage breast cancer patients
OncoTargets and Therapy·2018· 14 citedOpen Access
Abstract P6-09-09: Meta-analysis of ESR1 mutation prevalence in metastatic breast cancer
Cancer Research·2018
Los linfocitos estromales intratumorales (tils) como factor pronóstico en tumores primarios de mama Triple Negativos
2018
Independent prognostic impact of lympho-vascular invasion in cutaneous melanoma patients with sentinel lymph node biopsy
Annals of Oncology·2017
Eficacia de los inhibidores de ALK en dos casos con evaluación positiva por inmunohistoquímica y negativa por FISH
Oncología Clínica·2017Open Access
Abstract P6-09-40: Her2 and hormonal receptor analysis in breast cancer synchronic node metastases could add therapeutic information
Cancer Research·2017
High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers
Journal of Breast Cancer·2017· 8 citedOpen Access
TDM-1 en cáncer de mama metastásico her2 positivo
Oncología Clínica·2016Open Access
P2.12: Treatment Response in Patients With ALK Immunohistochemistry (IHC) Positive With Fish Negative
Journal of Thoracic Oncology·2016
P2.38: Nivolumab in Clinical Practice: Real World Experience in an Argentina Oncologic Center
Journal of Thoracic Oncology·2016· 1 citedOpen Access
Intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT): A risk group with heterogeneous behavior.
Journal of Clinical Oncology·2016
Translocated sarcomas: is molecular testing performed in adult sarcomas?
Journal of Clinical Oncology·2015

Frequent Co-authors

Pablo Mandó(10), Manglio Rizzo(8), Reinaldo Chacón(8), Jorge Nadal(7), Federico Coló(6), Adrián Nervo(6), Verónica Fabiano(5), Carmen Puparelli(4), Mora Amat(3), María Victoria Costanzo(3), Matías Chacón(3), Claudio Martín(3), C.M. Loza(3), C Ponce(3), Carlos Martín Loza(2), Carolina Ponce(2), Mercedes Maino(2), Federico Losco(2), Cristian Alexis Ostinelli(2), J. Loza(2)